Trial intelligence / Profile preview

Sex hormone treatment in Turner syndrome – estradiol regimens (project part B)

2019-004934-40Phase 4Active

Sponsor
Department of Endocrinology and Internal Medicine, Aarhus University Hospital
Start
Apr 2020
Countries
1
01

Overview

Phase 4 trial of estradiol in Turner syndrome (TS) (2 arms), sponsored by Department of Endocrinology and Internal Medicine, Aarhus University Hospital. Primary endpoint: Sex hormone level after washout period. Started Apr 2020; status: active.

02

Drugs

estradiol
03

Conditions

Turner syndrome (TS)

Beyond the preview

Go deeper on 2019-004934-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-004934-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call